CyLow (immediate release cyclosporine) / Sublimity Therap - LARVOL DELTA

High ratio of resident to exhausted CD4 + T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma. (PubMed, BMC Cancer) - "The ratio of resident to exhausted CD4 + T cells shows promise as a potential biomarker for HCC prognosis and immunotherapy response and SASS6 may serve as a biomarker and therapeutic target for prognostic assessment of HCC."

IO biomarker • Journal • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • CD4 • CD8

Decreased cobalamin sensitivity and biological aging acceleration in the general population. (PubMed, J Nutr Health Aging) - "Decreased cobalamin sensitivity but not cobalamin insufficiency might be associated with biological aging acceleration. Further studies would improve understanding of the underlying mechanisms between decreased cobalamin sensitivity and biological aging acceleration."

Journal

"This @ImperialNHS @ImperialMed #CylowVas regimen is very effective - lower doses #CyP, 2 x #rituximab achieve excellent remission & v low relapse rates. #AASV #Vasculitis @stephenmcadoo @Profcpusey @megan_griffith1 @RealDr_Pepper @THKC1" (@kidneydoc101)

Clinical